| Dermatitis, Atopic
Ebglyss vs Eucrisa
Side-by-side clinical, coverage, and cost comparison for dermatitis, atopic.Deep comparison between: Ebglyss vs Eucrisa with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsEucrisa has a higher rate of injection site reactions vs Ebglyss based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Eucrisa but not Ebglyss, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Ebglyss
Eucrisa
At A Glance
SC injection
Every 2-4 weeks
IL-13 antagonist
Topical
Twice daily
PDE-4 inhibitor
Indications
- Dermatitis, Atopic
- Dermatitis, Atopic
Dosing
Dermatitis, Atopic 500 mg (two 250 mg injections) SC at Week 0 and Week 2, then 250 mg every 2 weeks until Week 16 or adequate clinical response; maintenance dose is 250 mg every 4 weeks SC.
Dermatitis, Atopic Apply a thin layer twice daily to affected areas; once clinical effect is achieved, consider reducing to once daily. For topical use only.
Contraindications
- Prior serious hypersensitivity to lebrikizumab-lbkz or any excipient of EBGLYSS
- Known hypersensitivity to crisaborole or any component of the formulation
Adverse Reactions
Most common (>=1%) conjunctivitis, injection site reactions, herpes zoster
Serious hypersensitivity, conjunctivitis, keratitis
Most common (>=1%) Application site pain
Postmarketing Allergic contact dermatitis
Pharmacology
Lebrikizumab-lbkz is an IgG4 monoclonal antibody that binds with high affinity to IL-13, inhibiting IL-13 signaling through the IL-4Ra/IL-13Ra1 receptor complex; IL-13 is a cytokine central to Type 2 inflammation in atopic dermatitis pathogenesis.
Crisaborole is a phosphodiesterase 4 (PDE-4) inhibitor; PDE-4 inhibition results in increased intracellular cyclic adenosine monophosphate (cAMP) levels, though the specific mechanism by which it treats atopic dermatitis is not well defined.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Ebglyss
- Covered on 5 commercial plans
- PA (10/12) · Step Therapy (10/12) · Qty limit (9/12)
Eucrisa
- Covered on 5 commercial plans
- PA (9/12) · Step Therapy (10/12) · Qty limit (9/12)
UnitedHealthcare
Ebglyss
- Covered on 4 commercial plans
- PA (8/8) · Step Therapy (8/8) · Qty limit (4/8)
Eucrisa
- Covered on 4 commercial plans
- PA (1/8) · Step Therapy (4/8) · Qty limit (5/8)
Humana
Ebglyss
- Covered on 0 commercial plans
- PA (3/3) · Step Therapy (3/3) · Qty limit (3/3)
Eucrisa
- Covered on 0 commercial plans
- PA (3/3) · Step Therapy (3/3) · Qty limit (3/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
$25/momo
Ebglyss Savings Card - Non-covered benefitCommercial or private insurance
Medicare, Medicaid, VA, TRICARE
No savings programs available for Eucrisa.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
EbglyssView full Ebglyss profile
EucrisaView full Eucrisa profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.